Low-Dose Danazol for the Treatment of Telomere Related Diseases

NCT03312400 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

NIH

Sponsor class

Conditions

Telomere Disease

Interventions

DRUG: Danazol

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)